Abstract |
The aim of this study was to investigate if graft-versus- leukemia (GVL) activity conferred by allogeneic stem cell transplantation (allo-SCT) is effective in chronic lymphocytic leukemia (CLL) with unmutated V(H) gene status. The kinetics of residual disease (MRD) were measured by quantitative allele-specific immunoglobulin heavy chain (IgH) polymerase chain reaction (PCR) in 9 patients after nonmyeloablative allo-SCT for unmutated CLL. Despite an only modest decrease in the early posttransplantation phase, MRD became undetectable in 7 of 9 patients (78%) from day +100 onwards subsequent to chronic graft-versus-host disease or donor lymphocyte infusions. With a median follow-up of 25 months (range, 14-37 months), these 7 patients remain in continuous clinical and molecular remission. In contrast, PCR negativity was achieved in only 6 of 26 control patients (23%) after autologous SCT for unmutated CLL and it was not durable. Taken together, this study shows for the first time that GVL-mediated immunotherapy might be effective in CLL with unmutated V(H).
|
Authors | Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, Andreas Humpe, Monika Brüggemann, Christiane Pott, Thorsten Raff, Alexander Kröber, Donald Bunjes, Richard Schlenk, Norbert Schmitz, Hartmut Döhner, Michael Kneba, Peter Dreger |
Journal | Blood
(Blood)
Vol. 104
Issue 8
Pg. 2600-2
(Oct 15 2004)
ISSN: 0006-4971 [Print] United States |
PMID | 15205268
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Immunoglobulin Heavy Chains
|
Topics |
- Adult
- Female
- Graft vs Host Disease
(immunology)
- Humans
- Immunoglobulin Heavy Chains
(genetics)
- Immunotherapy
(methods)
- Kinetics
- Leukemia, Lymphocytic, Chronic, B-Cell
(genetics, immunology, therapy)
- Male
- Middle Aged
- Neoplasm, Residual
(diagnosis, genetics, immunology)
- Polymerase Chain Reaction
- Stem Cell Transplantation
- Transplantation Immunology
- Transplantation, Homologous
(immunology)
|